A phase i study to characterize the safety, tolerability, and pharmacokinetics of topotecan at 4 mg/m2 administered weekly as a 30-minute intravenous infusion in patients with cancer

Kelly K. Curtis, Jean T. Hartney, Roxanne C. Jewell, Jung W. Park, Peter F. Lebowitz, Pamela P. Griffin, Mitesh J. Borad, Tom R. Fitch, Donald W. Northfelt

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'A phase i study to characterize the safety, tolerability, and pharmacokinetics of topotecan at 4 mg/m<sup>2</sup> administered weekly as a 30-minute intravenous infusion in patients with cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences